UNOMINDA.NS(UNOMINDA.NS)
UNOMINDA.NS
No analyst ratings available
No analyst price targets available for UNOMINDA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $232.38B | $272.00B | $318.08B | $395.51B |
| Low | $222.17B | $252.50B | $299.34B | $372.20B |
| High | $246.35B | $292.59B | $339.87B | $422.61B |
| EBITDA Avg | $32.58B | $38.13B | $44.59B | $55.45B |
| Low | $31.15B | $35.40B | $41.97B | $52.18B |
| High | $34.54B | $41.02B | $47.65B | $59.25B |
| EBIT Avg | $27.01B | $31.61B | $36.97B | $45.97B |
| Low | $25.82B | $29.35B | $34.79B | $43.26B |
| High | $28.63B | $34.01B | $39.50B | $49.12B |
| Net Income Avg | $13.86B | $17.65B | $22.96B | $27.12B |
| Low | $12.63B | $14.77B | $21.20B | $25.04B |
| High | $14.95B | $21.51B | $25.00B | $29.53B |
| EPS Avg | $24.02 | $30.59 | $39.79 | $47.00 |
| Low | $21.89 | $25.61 | $36.75 | $43.40 |
| High | $25.90 | $37.29 | $43.34 | $51.19 |
| Analysts (Rev / EPS) | 17 / 16 | 17 / 17 | 15 / 14 | 8 / 7 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $57.77B | $59.00B | $63.49B |
| Low | $57.48B | $58.70B | $63.17B |
| High | $58.07B | $59.31B | $63.82B |
| EBITDA Avg | $8.10B | $8.27B | $8.90B |
| Low | $8.06B | $8.23B | $8.86B |
| High | $8.14B | $8.31B | $8.95B |
| EBIT Avg | $6.72B | $6.86B | $7.38B |
| Low | $6.68B | $6.82B | $7.34B |
| High | $6.75B | $6.89B | $7.42B |
| Net Income Avg | $3.45B | $3.41B | $3.88B |
| Low | $3.35B | $3.39B | $3.86B |
| High | $3.54B | $3.44B | $3.91B |
| EPS Avg | $5.96 | $5.91 | $6.72 |
| Low | $5.80 | $5.87 | $6.68 |
| High | $6.13 | $5.95 | $6.76 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 |